Jittery investors pulled nearly $22 billion from stock and bond mutual funds in September when Wall Street’s meltdown set the stage for a full-blown global financial crisis, Financial Research Corp. said.

Lees meer..

Genentech Inc. will be paid $31.5 million upfront in a deal with Biogen Idec. (BIIB) (DNA)

Lees meer..

BioCryst Pharmaceuticals Inc. reported a third-quarter 2008 net loss of $9 million, an 18 percent improvement of the same period in 2007.

Lees meer..

Vanda Pharmaceuticals Inc., which got hit with the news during the third quarter that its lead drug candidate was rejected by the Food and Drug Administration, says it is cutting 15 percent of its work force and suspending all commercial and development activities. (VNDA)

Lees meer..

ViroPharma Inc. topped Deloitte LLC’s Greater Philadelphia Fast 50, which was released Thursday.

Lees meer..

Meridian Bioscience said it plans to introduce a molecular test for C. difficile, a common cause of hospital-based infections, in the second half of its 2009 fiscal year. (VIVO)

Lees meer..